![Cynthia Summers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cynthia Summers
Public Communications Contact chez
Guttmacher Institute, Inc.
Profil
Cynthia Summers is currently the Vice President-Communications & Publications at Guttmacher Institute, Inc. She previously worked as the Executive Director at New York City Department of Health & Mental Hygiene and as the Director-Marketing & Public Affairs at Danco Laboratories LLC.
Dr. Summers completed her undergraduate degree at the University of Utah, her graduate degree at San Diego State University, and her doctorate at the University of Illinois.
Postes actifs de Cynthia Summers
| Sociétés | Poste | Début |
|---|---|---|
Guttmacher Institute, Inc.
 Guttmacher Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes reproductive health awareness program | Public Communications Contact | - |
Anciens postes connus de Cynthia Summers
| Sociétés | Poste | Fin |
|---|---|---|
Danco Laboratories LLC
 Danco Laboratories LLC Pharmaceuticals: MajorHealth Technology Danco Laboratories LLC manufactures Mifeprex (mifepristone), an FDA-approved medication used as a non-surgical option for terminating early intrauterine pregnancy up to 70 days gestation. The private company is based in DE. Mifeprex is administered with misoprostol to induce abortion by blocking progesterone, and is available only through a restricted Risk Evaluation and Mitigation Strategy (REMS) program requiring certified healthcare providers and pharmacies. Patients must be counseled on risks, benefits, and emergency procedures, and follow up with their healthcare provider after treatment. The medication has specific contraindications and potential adverse events, and Danco Laboratories offers resources for healthcare professionals, pharmacies, and patients regarding prescribing information, safety guidelines, and state law resources. | Public Communications Contact | - |
New York City Department of Health & Mental Hygiene
 New York City Department of Health & Mental Hygiene General GovernmentGovernment Provides health, safety and disease prevention services | Directeur/Membre du Conseil | - |
Formation de Cynthia Summers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guttmacher Institute, Inc.
Guttmacher Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes reproductive health awareness program | Commercial Services |
New York City Department of Health & Mental Hygiene
New York City Department of Health & Mental Hygiene General GovernmentGovernment Provides health, safety and disease prevention services | Government |
Danco Laboratories LLC
Danco Laboratories LLC Pharmaceuticals: MajorHealth Technology Danco Laboratories LLC manufactures Mifeprex (mifepristone), an FDA-approved medication used as a non-surgical option for terminating early intrauterine pregnancy up to 70 days gestation. The private company is based in DE. Mifeprex is administered with misoprostol to induce abortion by blocking progesterone, and is available only through a restricted Risk Evaluation and Mitigation Strategy (REMS) program requiring certified healthcare providers and pharmacies. Patients must be counseled on risks, benefits, and emergency procedures, and follow up with their healthcare provider after treatment. The medication has specific contraindications and potential adverse events, and Danco Laboratories offers resources for healthcare professionals, pharmacies, and patients regarding prescribing information, safety guidelines, and state law resources. | Health Technology |
